反応式
CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[OH:25][C:26]1[CH:27]=[C:28]2[C:32](=[CH:33][CH:34]=1)[NH:31][CH:30]=[C:29]2[CH2:35][C:36]([OH:38])=O.CCN(C(C)C)C(C)C.[F:48][C:49]1[CH:50]=[C:51]([CH2:56][CH:57]([C:59]2[N:60]=[CH:61][S:62][C:63]=2[C:64]2[CH:69]=[CH:68][CH:67]=[CH:66][C:65]=2[CH3:70])[NH2:58])[CH:52]=[C:53]([F:55])[CH:54]=1>CN(C=O)C>[F:48][C:49]1[CH:50]=[C:51]([CH2:56][CH:57]([NH:58][C:36](=[O:38])[CH2:35][C:29]2[C:28]3[C:32](=[CH:33][CH:34]=[C:26]([OH:25])[CH:27]=3)[NH:31][CH:30]=2)[C:59]2[N:60]=[CH:61][S:62][C:63]=2[C:64]2[CH:69]=[CH:68][CH:67]=[CH:66][C:65]=2[CH3:70])[CH:52]=[C:53]([F:55])[CH:54]=1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
HATU (40 mg, 0.105 mmol) was added to a solution of 2-(5-hydroxy-1H-indol-3-yl)acetic acid (19.2 mg, 0.1 mmol) and DIPEA (0.02 mL, 0.12 mmol) in DMF (0.3 mL). After 10 minutes, 13D (33.1 mg, 0.1 mmol) in 0.2 mL of DMF was added to the reaction. The reaction was stirred for 2 hours. LC/MS shows desired product. Purified reaction mixture on prep reverse phase HPLC using 20-80% B over 20 min. (A=0.1% TFA/H2O; B=0.1% TFA/Acetonitrile). Combined pure fractions as determined by LC/MS and lyophilized to provide the desired product. 1H NMR (400 MHz, DMSO) δ 10.46 (s, 1H), 9.18 (s, 1H), 8.31 (d, J=8.2 Hz, 1H), 7.35-7.15 (m, 2H), 7.05 (t, J=7.1 Hz, 2H), 6.94 (dd, J=10.2, 5.8 Hz, 2H), 6.75 (t, J=7.2 Hz, 2H), 6.59-6.35 (m, 3H), 3.38 (s, 2H), 3.01 (d, J=7.5 Hz, 2H), 1.81 (s, 3H). MS (m/z) 504 [M+H]+.
出典と根拠
- ORDレコード
- ord-bcb53f6eb1a444eeb1d93a335032e621
- 出典データセット
- uspto-grants-2015_12
- 特許番号
- US09220710B2
関連ノート
読み込み中…